248 results
Page 3 of 13
POS AM
3ds5z81etpczyrij
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm
POSASR
phjomu24ht9
23 Mar 22
Automatic shelf registration (post-effective amendment)
4:37pm
8-K
253scnnw szq7gf7
18 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
EX-99.1
meo7v
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.2
6p4jo61exe 1gcby0
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
kmksyfbg55hvmdjkb46
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
lrl51
7 Mar 22
TherapeuticsMD Enters into a Definitive Agreement to Divest vitaCare to GoodRx
7:47am
8-K
r9u3 v8xl
3 Jan 22
Other Events
6:03am
8-K
3x16rm5gaf28 6pc
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
68udsopcd ijm
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
pqgfko9iwafmmzf66
8 Dec 21
Regulation FD Disclosure
6:55am
8-K
EX-99.1
fzhvjuno
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.3
397svd o5w5aku26
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.2
xg6rr e6761
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
S-8
EX-10.1
bojd2
15 Oct 21
Registration of securities for employees
5:01pm
8-K
2w72poc5
7 Sep 21
Other Events
6:50am
8-K
EX-99.1
qcjco93z03yy6
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
EX-10.1
ka2hu2w1uzcn8bm4q2d
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm